BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12860866)

  • 1. Long term effects of nisoldipine on the progression of coronary atherosclerosis and the occurrence of clinical events: the NICOLE study.
    Dens JA; Desmet WJ; Coussement P; De Scheerder IK; Kostopoulos K; Kerdsinchai P; Supanantaroek C; Piessens JH
    Heart; 2003 Aug; 89(8):887-92. PubMed ID: 12860866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of Nisoldipine for prevention of restenosis after percutaneous transluminal coronary angioplasty (results of the NICOLE study). NIsoldipine in COronary artery disease in LEuven.
    Dens JA; Desmet WJ; Coussement P; De Scheerder IK; Kostopoulos K; Kerdsinchai P; Supanantaroek C; Piessens JH
    Am J Cardiol; 2001 Jan; 87(1):28-33. PubMed ID: 11137829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of progression of coronary artery atherosclerosis to risk of cardiovascular events (from the Monitored Atherosclerosis Regression Study).
    Vigen C; Hodis HN; Selzer RH; Mahrer PR; Mack WJ
    Am J Cardiol; 2005 Jun; 95(11):1277-82. PubMed ID: 15904629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators.
    Pitt B; Byington RP; Furberg CD; Hunninghake DB; Mancini GB; Miller ME; Riley W
    Circulation; 2000 Sep; 102(13):1503-10. PubMed ID: 11004140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.
    Estacio RO; Jeffers BW; Hiatt WR; Biggerstaff SL; Gifford N; Schrier RW
    N Engl J Med; 1998 Mar; 338(10):645-52. PubMed ID: 9486993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis.
    Waters D; Lespérance J; Francetich M; Causey D; Théroux P; Chiang YK; Hudon G; Lemarbre L; Reitman M; Joyal M
    Circulation; 1990 Dec; 82(6):1940-53. PubMed ID: 2242520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.
    Nissen SE; Tuzcu EM; Libby P; Thompson PD; Ghali M; Garza D; Berman L; Shi H; Buebendorf E; Topol EJ;
    JAMA; 2004 Nov; 292(18):2217-25. PubMed ID: 15536108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nisoldipine CC: clinical experience in ischaemic heart disease.
    Melcher A; Dens J; Curry P; Hagel H
    Cardiology; 1997; 88 Suppl 1():17-23; discussion 24-5. PubMed ID: 9118164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cystatin C levels on angiographic atherosclerosis progression and events among postmenopausal women with angiographically decompensated coronary artery disease (from the Women's Angiographic Vitamin and Estrogen [WAVE] study).
    Patel D; Ahmad S; Silverman A; Lindsay J
    Am J Cardiol; 2013 Jun; 111(12):1681-7. PubMed ID: 23499273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: the randomized, double-blind, placebo-controlled, multicenter Verapamil Slow-Release for Prevention of Cardiovascular Events After Angioplasty (VESPA) Trial.
    Bestehorn HP; Neumann FJ; Büttner HJ; Betz P; Stürzenhofecker P; von Hodenberg E; Verdun A; Levai L; Monassier JP; Roskamm H
    J Am Coll Cardiol; 2004 Jun; 43(12):2160-5. PubMed ID: 15193674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International nifedipine trial on anti-atherosclerotic therapy (INTACT)--methodologic implications and results of a coronary angiographic follow-up study using computer-assisted film analysis.
    Jost S; Deckers J; Rafflenbeul W; Hecker H; Reiber JH; Nikutta P; Wiese B; Hugenholtz P; Lichtlen P
    Int J Card Imaging; 1990-1991; 6(2):117-33. PubMed ID: 2097305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.
    Weisz G; Généreux P; Iñiguez A; Zurakowski A; Shechter M; Alexander KP; Dressler O; Osmukhina A; James S; Ohman EM; Ben-Yehuda O; Farzaneh-Far R; Stone GW;
    Lancet; 2016 Jan; 387(10014):136-45. PubMed ID: 26474810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS).
    Lancet; 1994 Sep; 344(8923):633-8. PubMed ID: 7864934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An updated meta-analysis of calcium-channel blockers in the prevention of restenosis after coronary angioplasty.
    Dens J; Desmet W; Piessens J
    Am Heart J; 2003 Mar; 145(3):404-8. PubMed ID: 12660661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antianginal and anti-ischemic efficacy of nisoldipine in stable angina pectoris: a randomized, double-blind, placebo-controlled trial.
    Chen YH; Liu RC; Wang SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):323-8. PubMed ID: 9037847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial quantitative coronary angiography and coronary events.
    Mack WJ; Xiang M; Selzer RH; Hodis HN
    Am Heart J; 2000 Jun; 139(6):993-9. PubMed ID: 10827379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydropyridine calcium antagonists: beneficial or adverse effects in the setting of myocardial ischaemia/reperfusion?
    Ehring T; Heusch G
    Cardiology; 1997; 88 Suppl 1():3-14; discussion 15-6. PubMed ID: 9118166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No effect of highly dosed nitric oxide donor molsidomine on the angiographic restenosis rate after percutaneous coronary angioplasty: a randomized, placebo controlled, double-blind trial.
    Wöhrle J; Höher M; Nusser T; Hombach V; Kochs M
    Can J Cardiol; 2003 Apr; 19(5):495-500. PubMed ID: 12717484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of accelerated atherosclerotic disease progression after intracoronary infusion of bone marrow derived mononuclear cells in patients with acute myocardial infarction--angiographic and intravascular ultrasound--results from the TErapia Celular Aplicada al Miocardio Pilot study.
    Arnold R; Villa A; Gutiérrez H; Sánchez PL; Gimeno F; Fernández ME; Gutiérrez O; Mota P; Sánchez A; García-Frade J; Fernández-Avilés F; San Román JA;
    Am Heart J; 2010 Jun; 159(6):1154.e1-8. PubMed ID: 20569733
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.